HOME BLOOD PRESSURE MONITORING REDUCES HIGH BLOOD PRESSURE AND IMPROVES CONTROL
HOME BLOOD PRESSURE MONITORING REDUCES HIGH BLOOD PRESSURE AND IMPROVES CONTROL
New data presented at the World Congress of Cardiology
BEIJING, 19 JUNE 2010. Home Blood Pressure Monitoring (HBPM) device reduces blood pressure and improves control according to according to new data presented today at the World Congress of Cardiology (WCC) Scientific Sessions in Beijing, China.
A factorial randomized controlled clinical trial among adults undergoing drug treatment but with uncontrolled office blood pressure (≥140/90 mm Hg) and 24 hour ambulatory blood pressure monitoring – ABPM (≥130/80 mmHg) was carried out to determine the effect of HBPM on blood pressure control. The average of the delta for 24H systolic blood pressure differed between HBPM (8.8 ±12.9 mmHg) and control (3.4 ±11.6 mmHg) groups (p=0.018), as well as for 24h diastolic blood pressure (p=0.003). At the end of the trial 18.6 per cent of patients using HBPM compared with just 8.1 per cent of the control group had blood pressure <130/80 mmHg (p=0.08).
“Home Blood Press Monitoring devices have been used for a number of years to detect white-coat hypertension and to guide treatment decisions. Now we showed that they could improve therapeutic compliance” said Dr. Sandra C. Fuchs, Associate Professor of Federal University of Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. “This study set out to measure the effect of home blood pressure monitoring devices on lowering blood pressure.”
Participants with uncontrolled office blood pressure and 24 hour ambulatory blood pressure (≥130/80 mmHg) were randomly assigned to four different groups - HBPM (n=36), pharmacist care (n=35), HBPM and pharmacist care (n=32) or usual care (n=33). Medication was not changed during the trial. Blood pressure measurements were taken at 7 and 30 days after randomization, and at 60 days to assess the outcome. This was a pooled analysis of the intervention (HBPM + HBPM with pharmacist care) versus control (pharmacist care + usual care).
About the World Congress of Cardiology
The World Congress of Cardiology Scientific Sessions is the official congress of the World Heart Federation and is held every two years. Through the Congress the World Heart Federation offers an international stage for the latest developments in science and public outreach in the field of cardiovascular health. The World Congress of Cardiology places emphasis on the complementary nature of science and public outreach and strives to spread the message that through individual, community and patient-care interventions, the growing epidemic of cardiovascular diseases can be prevented. www.worldcardiocongress.org
About the World Heart Federation
The World Heart Federation is dedicated to leading the global fight against heart disease and stroke with a focus on low- and middle-income countries via a united community of more than 200 member organizations. With its members, the World Heart Federation works to build global commitment to addressing cardiovascular health at the policy level, generates and exchanges ideas, shares best practice, advances scientific knowledge and promotes knowledge transfer to tackle cardiovascular disease – the world’s number one killer. It is a growing membership organization that brings together the strength of medical societies and heart foundations from more than 100 countries. Through our collective efforts we can help people all over the world to lead longer and better heart-healthy lives. For more information, please visit www.worldheart.org
<media 6574>Download the press release ></media>